The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Egorov A.Iu.

Institut évoliutsionnoĭ fiziologii i biokhimii im. I.M. Sechenova RAN

The treatment of non-chemical addictions

Authors:

Egorov A.Iu.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(6): 115‑123

DOI: 10.17116/jnevro201811861115

Read: 9171 times

Download PDF (RU)
Contact the author
Table of contents

THE TREATMENT OF NON-CHEMICAL ADDICTIONS
THE TREATMENT OF NON-CHEMICAL ADDICTIONS

To cite this article:

Egorov AIu. The treatment of non-chemical addictions. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(6):115‑123. (In Russ.)
https://doi.org/10.17116/jnevro201811861115

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Evaluation of the effe­ctiveness of the drug Cortexin in combination with the use of the application Apha­sia.No (Afaziyam.Net) in the correction of speech diso­rders in patients with cere­bral infa­rction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):147-151
Therapeutic targets of adolescent depression with atte­nuated symptoms of schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):69-74
The asso­ciation of NOS1AP gene poly­morphisms with the dura­tion of the QT inte­rval in patients with schi­zophrenia receiving anti­psychotic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):98-104
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Evaluation of the impact of a comprehensive reha­bilitation program on improving nutritional status, psychoemotional signs and adve­rse events in patients with mela­noma after surgical treatment. Piro­gov Russian Journal of Surgery. 2024;(12-2):173-178
The effe­ctiveness of wellness programs in correcting risk factors for athe­rosclerosis in a sana­torium. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):102-109
Characteristics, treatment features and in-hospital mortality of patients with myocardial infa­rction over 75 years old in Russia acco­rding to the REGION-IM regi­stry. Russian Cardiology Bulletin. 2025;(1):22-38
Correction of myopia with implantable collamer lenses. Russian Annals of Ophthalmology. 2025;(2):5-15
Chro­nic obstructive pulmonary disease (COPD 2024). Clinical guidelines (short version). Journal of Respiratory Medi­cine. 2025;(2):5-16
Abstract:

Today, there are no standards of therapy for non-chemical (behavioral) addictions. The article examines in detail modern psychological (classes in the 12 step program groups, various psychotherapeutic interventions) and pharmacological (antidepressants, opioid receptor antagonists, normotimics, glutamatergic agents, etc.) approaches to the treatment of pathological gambling. The possibilities of therapy of love and sexual addiction are analyzed. Separately, the problems of correction of the so-called socially acceptable addictions, as well as Internet addictions, are considered. The extremely cautious tactics in the therapy of these forms is recommended, because they can transform into heavy chemical and behavioral addictions. The importance of using a number of socially acceptable addictions as substitutes for the treatment of severe forms of dependences is underlined. In conclusion, the questions of the competency of a psychiatrist-addiction specialist and a psychologist in the correction of behavioral dependencies are analyzed and indications for psychopharmacotherapy are determined.

Keywords:

non-chemical (behavioral) addictions
therapy
correction
psychotherapy
psychopharmacotherapy

Authors:

Egorov A.Iu.

Institut évoliutsionnoĭ fiziologii i biokhimii im. I.M. Sechenova RAN

Close metadata

References:

  1. Egorov AYu. Nekhimicheskie addiktsii. SPb.: Rech’; 2007. (In Russ.)
  2. Egorov AY, Szabo A, Fel’sendorf OV. Modeli sportivnoi addiktsii. Voprosy psikhologii. 2016;3:(96-109). (In Russ.)
  3. Brown RI. The effectiveness of Gamblers Anonymous. Gambling Studies: Proceedings of the Sixth National Conference on Gambling and Risk Taking: Vol 5: The Phenomenon of Pathological Gambling. Eadington WR, ed. Reno: University of Nevada, Bureau of Business and Economic Administration; 1985.
  4. Lester D. The treatment of compulsive gambling. International Journal of the Addictions. 1980;15:201-206.
  5. Stewart R, Brown RI. The outcome study of Gamblers Anonymous. Br J Psychiatry. 1988;152:284-288.
  6. Russo AM, Taber JI, McCormick RA, et al: An outcome study of an inpatient treatment program for pathological gamblers. Hospital and Community Psychiatry. 1984;35:823-827.
  7. Blaszczynski AP, McConaghy N, Frankova A. Control versus abstinence in the treatment of pathological gambling: a two- to nine-year follow-up. British Journal of Addiction. 1991;86:299-306.
  8. Bujold A, Ladouceur R, Sylvain C, Boisvert JM. Treatment of pathological gamblers: an experimental study. Journal of Behavioral Therapy and Experimental Psychiatry. 1994;25:275-282.
  9. Sylvian C, Ladouceur R, Boisvert JM. Cognitive and behavioral treatment of pathological gambling: a controlled study. Journal of Consulting and Clinical Psychology. 1997;65:727-732.
  10. Mladenović I, Lažetić G, Lečić-Toševski D, Dimitrijević I. Treatment of pathological gambling — integrative systemic model. Psychiatr Danub. 2015;27(1):107-111.
  11. Myrseth H, Litlerè I, Støylen IJ, Pallesen S. A controlled study of the effect of cognitive-behavioral group therapy for pathological gamblers. Nord J Psychiatry. 2009;63(1):22-31. https://doi.org/10.1080/08039480802055139
  12. Wong DF, Chung CL, Wu J, Tang J, Lau P, Wan JP. A preliminary study of an integrated and culturally attuned cognitive behavioral group treatment for Chinese problem gamblers in Hong Kong. J Gambl Stud. 2015;31(3): 1015-1027. https://doi.org/10.1007/s10899-014-9457-2
  13. Oei TP, Raylu N, Casey LM. Effectiveness of group and individual formats of a combined motivational interviewing and cognitive behavioral treatment program for problem gambling: a randomized controlled trial. Behav Cogn Psychother. 2010;38(2):233-238. https://doi.org/10.1017/S1352465809990701
  14. Carlbring P, Degerman N, Jonsson J, Andersson G. Internet-based treatment of pathological gambling with a three-year follow-up. Cogn Behav Ther. 2012;41(4):321-334. https://doi.org/10.1080/16506073.2012.689323
  15. Egorov AYu. Sovremennye podkhody k terapii igrovoi zavisimosti. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2014;114(5)(supl 2):46-52. (In Russ.)
  16. Egorov AYu. Terapiya igrovoi zavisimosti. In Nauchno-prakticheskaya konferentsiya s mezhdunarodnym uchastiem «Mir addiktsii: khimicheskie i nekhimicheskie zavisimosti, assotsiirovannye psikhicheskie rasstroistva». Tezisy konferentsii. Neznanov NG, Krupitsky EM, eds. SPb. 2012. (In Russ.)
  17. Cowlishaw S, Merkouris S, Dowling N, Anderson C, Jackson A, Thomas S. Psychological therapies for pathological and problem gambling. Cochrane Database Syst Rev. 2012;11:CD008937. https://doi.org/10.1002/14651858.CD008937.pub2
  18. DeCaria CM, Hollander E, Grossman R, Wong CM, Mosovich SA, Cherkasky S. Diagnosis, neurobiology, and treatment of pathological gambling. J Clin Psychiatry. 1996;7(suppl 8):80-83.
  19. Hollander E, Frenkel M, DeCaria C, et al: Treatment of pathological gambling with clomipramine. American Journal of Psychiatry. 1992;149:710-711.
  20. Hollander E, DeCaria C, Mari E, et al: Short-term single-blind fluvoxamine treatment of pathological gambling. American Journal of Psychiatry. 1998;155:1781-1783. https://doi.org/10.1176/ajp.155.12.1781
  21. Hollander E, DeCaria C, Frenkel M, Begaz T, Wong C, Cartwrite C. A randomized double blind fluvoxamine/placebo crossover trial in pathological gambling. Biol Psychiatry. 2000;47:813-817.
  22. Blanco C, Petkova E, Ibáñez A, Sáiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. J Ann Clin Psychiatry. 2002;14(1):9-15.
  23. Grant JE, Kim SW, Potenza MN, Blanco C, Ibanez A, Stevens L, Hektner JM, Zaninelli R. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int Clin Psychopharmacol. 2003;18(4):243-249. https://doi.org/10.1097/01.yic.0000073881.93678.21
  24. Saiz-Ruiz J, Blanco C, Ibáñez A, Masramon X, Gómez MM, Madrigal M, Díez T. Sertraline treatment of pathological gambling: a pilot study. J Clin Psychiatry. 2005;66(1):28-33.
  25. Dannon PN, Lowengrub K, Musin E, Gonopolski Y, Kotler M. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study. J Clin Psychopharmacol. 2005;25(6): 593-596.
  26. Black DW, Arndt S, Coryell WH, Argo T, Forbush KT, Shaw MC, Perry P, Allen J. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. J Clin Psychopharmacol. 2007;27(2):143-150. https://doi.org/10.1097/01.jcp.0000264985.25109.25
  27. Black DW, Shaw M, Forbush KT, Allen J. An open-label trial of escitalopram in the treatment of pathological gambling. Clin Neuropharmacol. 2007;30(4):206-212. https://doi.org/10.1097/wnf.0b013e31803d357f
  28. Grant JE, Potenza MN. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Int Clin Psychopharmacol. 2006;21(4):203-209.
  29. Egorov AY. Ispol’zovanie agomelatina (val’doksan) v terapii gemblinga: pilotnoe issledovanie. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;115(9):28-31. (In Russ.) https://doi.org/10.17116/jnevro20151159128-31.
  30. Rosenberg O, Dinur LK, Dannon PN. Four-year follow-up study of pharmacological treatment in pathological gamblers. Clin Neuropharmacol. 2013;36(2):42-45. https://doi.org/10.1097/WNF.0b013e31828740ea
  31. Kim SW, Grant J. Psychopharmacology of pathological gambling. Semin Clin Neuropsyhiatry. 2001;6:184-194.
  32. Grant JE, Kim SW, Hartman BK. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry. 2008;69(5):783-789.
  33. Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. American Journal of Psychiatry. 2006;163:303-312. https://doi.org/10.1176/appi.ajp.163.2.303
  34. Grant JE, Potenza MN, Hollander E, Kim SW. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. The British Journal of Psychiatry. 2010;197:330-331. https://doi.org/10.1192/bjp.bp.110.078105
  35. Black DW, Shaw MC, Allen J. Extended release carbamazepine in the treatment of pathological gambling: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1191-1194. https://doi.org/10.1016/j.pnpbp.2008.02.013
  36. Dannon PN, Lowengrub K, Gonopolski Y, Musin E. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol. 2005;28(1):6-10.
  37. Pallanti S, Quercioli L, Sood E, Hollander E. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry. 2002;63(7):559-564.
  38. Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry. 2005;162(1):137-145. https://doi.org/10.1176/appi.ajp.162.1.137
  39. Chaim CH, Nazar BP, Hollander E, Lessa JL. Pathological gambling treated with lithium: the role of assessing temperament. Addict Behav. 2014;39(12):1911-1913. https://doi.org/10.1016/j.addbeh.2014.05.016
  40. Grant JE, Chamberlain SR, Odlaug BL, Potenza MN, Kim SW. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl). 2010;212(4):603-612. https://doi.org/10.1007/s00213-010-1994-5
  41. Grant JE, Kim SW, Odlaug BL. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry. 2007;62(6):652-657. https://doi.org/10.1016/j.biopsych.2006.11.021
  42. Grant JE, Odlaug BL, Chamberlain SR, Potenza M., Schreiber LR, Donahue CB, Kim SW. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. J Clin Psychiatry. 2014;75(1)39-45. https://doi.org/10.4088/JCP.13m08411
  43. McElroy SL, Nelson EB, Welge JA, Kaehler L, Keck Jr P. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. J Clin Psychiatry. 2008;69(3):433-440.
  44. Fong T, Kalechstein A, Bernhard B, Rosenthal R, Rugle L. A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol Biochem Behav. 2008;89(3):298-303. https://doi.org/10.1016/j.pbb.2007.12.025
  45. Gaboriau L Victorri-Vigneau C, Gérardin M, Allain-Veyrac G, Jolliet-Evin P, Grall-Bronnec M. Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports. Addict Behav. 2014;39(3):562-565. https://doi.org/10.1016/j.addbeh.2013.11.005
  46. Black DW, McNeilly DP, Burke WJ, Shaw MC, Allen J. An open-label trial of acamprosate in the treatment of pathological gambling. Ann Clin Psychiatry. 2011;23(4):250-256.
  47. Zack M, Poulos CX. Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity. J Psychopharmacol. 2009;23(6):660-671. https://doi.org/10.1177/0269881108091072
  48. Pallesen S, Mitsem M, Kvale G, Johnsen BH, Molde H. Outcome of psychological treatments of pathological gambling: a review and meta-analysis. Addiction. 2005;100(10):1412-1422. https://doi.org/10.1111/j.1360-0443.2005.01204.x
  49. Khmaruk IN, Stepanova YS. Social’no-psihologicheskaya predispozitcia formirovania eroticheskih addiktcii. Bekhterev V.M. i sovremennaya psikhologiya. Materialy dokladov na rossiiskoi nauchno-prakticheskoi konferentsii. Kazan’, KGU, 29—30 sentyabrya 2005 g. Vyp. 3. T. 2. Kazan’: Tsentr innovatsionnykh tekhnologii; 2005;332-338. (In Russ.)
  50. Schneider JP, Irons RR. Assessment and treatment of addictive sexual disorders: relevance for chemical dependency relapse. Subst Use Misuse. 2001;36(13):1795-1820.
  51. Lorena A, Sophia EC, Mello C, Tavares H, Zilberman ML. Group therapy for pathological love. Rev Bras Psiquiatr. 2008;30(3):292-293.
  52. Azhar MZ, Varma SL. Response of clomipramine in sexual addiction. European Psychiatry. 1995;10(5):263-264. https://doi.org/10.1016/0924-9338(96)80304-X
  53. Fedoroff JP. Serotonergic drug treatment of deviant sexual interests. Annals of Sex Research. 1993;6:105-121.
  54. Kafka MP. Psychopharmacologic treatments for nonparaphilic compulsive sexual behaviors. CNS Spectrums. 2000;5(1):49-59.
  55. Wainberg ML, Muench F, Morgenstern J, Hollander E, Irwin TW, Parsons JT, Allen A, O’Leary A. A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. J Clin Psychiatry. 2006;67:1968-1973.
  56. Kafka MP, Prentky R. Fluoxetine treatment of non-paraphilic sexual addictions and paraphilias in men. J Clin Psychiatry. 1992;53:351-358.
  57. Raymond NC, Grant JE, Coleman E. Augmentation with naltrexone to treat compulsive sexual behavior: a case series. Ann Clin Psychiatry. 2010;22(7):56-62.
  58. Ryback RS. Naltrexone in the treatment of adolescent sexual offenders. J Clin Psychiatry. 2004;65(7):982-986.
  59. Garcia FD, Thibaut F. Sexual addictions. The American Journal of Drug and Alcohol Abuse. 2010;36:254-260. https://doi.org/10.3109/00952990.2010.503823
  60. Petry NM, Rehbein F, Gentile DA, Lemmens JS, Rumpf HJ, Mößle T, Bischof G, Tao R, Fung DS, Borges G, Auriacombe M, González Ibáñez A, Tam P, O’Brien CP. An international consensus for assessing internet gaming disorder using the new DSM-5 approach. Addiction. 2014;109(9): 1399-1406. https://doi.org/10.1111/add.12457
  61. Thorens G, Khazaal, Billieux, Van der Linden, Zullino D. Swiss Psychiatrists’ Beliefs and Attitudes about Internet Addiction. The Psyhiatric Q. 2009;80(2):117-123. https://doi.org/10.1007/s11126-009-9098-2
  62. King D, Delfabbro P, Griffiths M, Gradisar M. Assessing clinical trials of Internet addiction treatment: A systematic review and CONSORT evaluation. Clinical Psychology Review. 2011;31(7):1110-1116. https://doi.org/10.1016/j.cpr.2011.06.009
  63. Brezing C, Derevensky J, Potenza MN. Non-substance addictive behaviors in youth: Pathological gambling and problematic internet use. Child Adolesc Psychiatr Clin N Am. 2010;19(3):625—641. https://doi.org/10.1016/j.chc.2010.03.012
  64. Chakraborty K, Basu D, Vijaya Kumar KG. Internet addiction: Consensus, controversies, and the way ahead. East Asian Arch Psychiatry. 2010;20:123-132.
  65. Winkler A, Dörsing B, Rief W, Shen Y, Glombiewski JA. Treatment of internet addiction: a meta-analysis. Clin Psychol Rev. 2013;33(2):317-329. https://doi.org/10.1016/j.cpr.2012.12.005
  66. Young KS. Internet addiction: Symptoms, evaluation, and treatment. Innovations in Clinical Practice (Vol. 17). Vande-Creek L, Jackson T, eds; Sarasota, FL: Professional Resource Press; 1999.
  67. Young KS. CBT-IA: The first treatment model to address Internet addiction. Journal of Cognitive Therapy. 2011;25:304—312. https://doi.org/10.1556/JBA.2.2013.4.3
  68. Young KS. Treatment outcomes using CBT-IA with Internet-addicted patients. Journal of Behavioral Addictions. 2013;2(4):209—215. https://doi.org/10.1556/JBA.2.2013.4.3
  69. Davis SA. A cognitive-behavioral model of pathological Internet use. Computers in Human Behavior. 2001;17(2);187-195.
  70. Shaw M, Black DW. Internet addiction: definition, assessment, epidemiology and clinical management. CNS Drugs. 008;22(5):353-365.
  71. Southern S. Treatment of compulsive cybersex behavior. Psychiatr Clin North Am. 2008;31(4):697-712. https://doi.org/10.1016/j.psc.2008.06.003
  72. Zhu TM, Jin RJ, Zhong XM. Effects of electroacupuncture combined with psychologic interference on anxiety state and serum NE content in the patient of internet addiction disorder. Zhongguo Zhen Jiu. 2008;28(8):561-564. (In Chinese).
  73. Young KS, Case CJ. Internet abuse in the workplace: new trends in risk management. Cyberpsychology and Behavior. 2004;7(1):105-111. https://doi.org/10.1089/109493104322820174
  74. Meenan A. Internet gaming: A hidden addiction. American Family Physician. 2007;15:1116.
  75. Thorens G, Achab S, Billieux J, et al. Characteristics and treatment response of self-identified problematic Internet users in a behavioral addiction outpatient clinic. Journal of Behavioral Addictions. 2014;3(1):78-81. https://doi.org/10.1556/JBA.3.2014.008
  76. Du Y, Jiang W, Vance A. Longer term effect of randomized, controlled group cognitive behavioral therapy for Internet addiction in adolescent students in Shanghai. The Australian and New Zealand Journal of Psychiatry. 2010;44:129-134. https://doi.org/10.3109/00048670903282725
  77. Bostwick JM, Bucci JA. Internet sex addiction treated with naltrexone. Mayo Clin Proc. 2008;83(2):226-230. https://doi.org/10.4065/83.2.226
  78. Dell’Osso B, Hadley S, Allen A, et al. Escitalopram in the treatment of impulsive-compulsive Internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. Journal of Clinical Psychiatry. 2008;69(3):52-56.
  79. Atmaca M. A case of problematic internet use successfully treated with an SSRI-antipsychotic combination. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(4):961-962. https://doi.org/10.1016/j.pnpbp.2007.01.003
  80. Han DH, Lee YS, Na C, et al The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder. Compr Psychiatry. 2009;50(3):251-256. https://doi.org/10.1016/j.comppsych.2008.08.011
  81. Han DH, Renshaw PF. Bupropion in the treatment of problematic online game play in patients with major depressive disorder. J Psychopharmacol. 2012;26(5):689-696. https://doi.org/10.1177/0269881111400647
  82. McElroy SL, Satlin A, Pope Jr H, Keck Jr P, Hudson J. Treatment of compulsive shopping with antidepressants: A report of three cases. Annals of Clinical Psychiatry. 1991;3:199-204.
  83. Black DW, Monahan P, Gabel J. Fluvoxamine in the treatment of compulsive buying. Journal of Clinical Psychiatry. 1997;58:159-163.
  84. Black DW, Gabel J, Hansen J, Schlosser S. A double-blind comparison of fluvoxamine versus placebo in the treatment of compulsive buying disorder. Annals of Clinical Psychiatry. 2000;12:205-211.
  85. Bullock K, Hartston H, Elliott M, D’Andrea,V, Koran L. Citalopram treatment of compulsive shopping: An open-label study. Presented at the annual meeting of the American College of Neuropsychopharmacology. December 10—14, 2000. San Juan, Puerto Rico; 2000.
  86. Koran LM, Faber RJ, Aboujaoude E, Large MD., Serpe R.T. Estimated prevalence of compulsive buying in the United States. Am J Psychiatry. 2006;163(10):1806-1812. https://doi.org/10.1176/ajp.2006.163.10.1806
  87. Lee S, Mysyk A. The medicalization of compulsive buying. Social Science & Medicine. 2004;58(9):1709-1718. https://doi.org/10.1016/S0277-9536(03)00340-X
  88. Grant JE, Odlaug BL, Mooney M, O’Brien R, Kim SW. Open-label pilot study of memantine in the treatment of compulsive buying. Ann Clin Psychiatry. 2012;24(2):119-126.
  89. Grant JE. Three cases of compulsive buying treated with naltrexone. International Journal of Psychiatry and Clinical Practice. 2003;7:223-225.
  90. Mitchell JE, Burgard M, Faber R, Crosby RD, de Zwaan M. Cognitive behavioral therapy for compulsive buying disorder. Behaviour Research and Therapy. 2006;44(12):1859-1865. https://doi.org/10.1016/j.brat.2005.12.009
  91. Mueller A, Mueller U, Silbermann A, Reinecker H, Bleich S, Mitchell JE., de Zwaan M. A randomized, controlled trial of group cognitive-behavioral therapy for compulsive buying disorder: Posttreatment and 6-month followup results. J Clinical Psychiatry. 2008;69:1131-1138.
  92. Marčinko D, Bolanča M, Rudan V. Compulsive buying and binge eating disorder — a case vignettes. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(8):1542-1544. https://doi.org/10.1016/j.pnpbp.2006.05.009
  93. Marčinko D, Karlovič D. Oniomania — successful treatment with fluvoxamine and cognitive-behavioural psychotherapy. Psychiatr Danub. 2005;17:97-100.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.